Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;10(7):786-94.
doi: 10.1016/j.cgh.2012.01.020. Epub 2012 Feb 14.

Association between puberty and features of nonalcoholic fatty liver disease

Collaborators, Affiliations

Association between puberty and features of nonalcoholic fatty liver disease

Ayako Suzuki et al. Clin Gastroenterol Hepatol. 2012 Jul.

Abstract

Background & aims: Physiological changes that occur during puberty might affect pathologic features of nonalcoholic fatty liver disease (NAFLD). We investigated associations between pubertal development and clinical and histopathologic features of NAFLD.

Methods: We studied 186 children (age <18 years, 143 boys) with biopsy-proven NAFLD. The population was divided into 3 groups on the basis of Tanner stage (prepuberty, puberty, and postpuberty). Clinical characteristics and histologic features were compared among groups. Multivariable regression models were used to adjust for potential confounders.

Results: After adjusting for other factors, hyperuricemia and low levels of high-density-lipoprotein cholesterol were more prevalent among children who entered puberty with lower levels of quantitative insulin sensitivity check index (P < .05). The degree of steatosis, numbers of Mallory-Denk bodies, and diagnostic categories of NAFLD differed among groups (P < .05). There were potential sex differences in associations between stages of puberty and lobular inflammation, hepatocyte ballooning, and borderline steatohepatitis of zone 3; these were therefore not included in multivariable analyses of the overall population. After adjustment for different sets of confounders, patients at or beyond puberty were less likely to have high-grade steatosis, severe portal inflammation, borderline steatohepatitis (zone 1), or a high stage of fibrosis than patients who had not entered puberty (P < .05). On the contrary, the prevalence of Mallory-Denk body was greater among postpuberty subjects (P = .06).

Conclusions: Steatosis, portal inflammation, and fibrosis are less severe during or after puberty than before puberty among subjects with NAFLD. Postpubescent individuals have a lower prevalence of borderline steatohepatitis of zone 1 but are more likely to have Mallory-Denk bodies. These findings indicate that puberty affects the pathologic features of NAFLD.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors report no conflict of interest.

Figures

Figure 1
Figure 1. Associations of Pubertal Development with Steatosis, Steatohepatitis, Mallory-Denk bodies, and Portal Inflammation in Total Population
Figures show the associations of pubertal stages (horizontal axis) with the prevalence of up to mild (grade 0–1), moderate (grade 2) and severe (grade 3) steatosis (left upper), the prevalence of none (simple steatosis), borderline steatohepatitis zone 3 (or adult pattern), borderline steatohepatitis zone 1(pediatric pattern), and definite steatohepatitis (right upper), the prevalence of severe (grade 2) portal inflammation (left lower), and the prevalence of Mallory-Denk bodies (right lower). P-values are from exact tests. SH: steatohepatitis

Similar articles

Cited by

References

    1. Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346:1221–31. - PubMed
    1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–93. - PubMed
    1. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58:1538–44. - PMC - PubMed
    1. Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology. 2009;50:1113–20. - PMC - PubMed
    1. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–9. - PubMed

Publication types

Grants and funding